D A Isenberg

发表

CNS Lupus—Where Do We Go From Here?

D A Isenberg, M H Liang, D. Isenberg, 1999, Lupus.

Structure–function analysis and the molecular origins of anti-DNA antibodies in systemic lupus erythematosus

D A Isenberg, D. Isenberg, Anisur Rahman, 1999, Expert Reviews in Molecular Medicine.

The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus.

D A Isenberg, D. Symmons, C. Gordon, 1993, The Quarterly journal of medicine.

Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus.

D A Isenberg, C. Gordon, D. Isenberg, 1997, The Journal of rheumatology.

ABC of Rheumatology: RAYNAUD'S PHENOMENON, SCLERODERMA, AND OVERLAP SYNDROMES

D A Isenberg, D. Isenberg, C. Black, 1995, BMJ.

Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome.

D A Isenberg, D. Isenberg, A. Jones, 2007, Rheumatology.

A review of gastrointestinal manifestations of systemic lupus erythematosus.

Y Ioannou, D A Isenberg, D. Isenberg, 1999, Rheumatology.

Treatment of inflammatory myopathies

D A Isenberg, D. Isenberg, A C Cordeiro, 2006, Postgraduate Medical Journal.

Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia

D S Latchman, D A Isenberg, D. Isenberg, 2005, Annals of the rheumatic diseases.

Development and initial validation of an updated version of the British Isles Lupus Assessment Group ’ s disease activity index for patients with systemic lupus erythematosus

D A Isenberg, I. Bruce, C. Gordon, 2005 .

From BILAG to BLIPS—disease activity assessment in lupus past, present and future

D A Isenberg, C. Gordon, D. Isenberg, 2000, Lupus.